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Abstract
The irst detailed description of calcifying epithelial odontogenic tumor (CEOT) are ascribed to Jens Pindborg, but this tumor 
was described some years previously. Subsequently, CEOT was included in the 1971 WHO classiication of odontogenic 
tumors and a since then number of variants have been described, which have added confusion to the diagnostic criteria. 
We aimed to survey the literature on the variants of CEOT, in parallel with a review of our single institution experience 
of CEOTs. Cases identiied were collated, including available clinical, radiological and histological information and then 
reviewed, taking into account changes in the understanding and classiications of odontogenic tumors since initial diagnosis. 
We identiied 26 cases from 1975 to 2017 for which histological material was available. Of these, only 13 (50%) showed the 
“classic” histological appearance, whilst two cases were identiied as recognized variants. In 11 cases, other diagnoses or a 
diferential diagnosis were preferred, with no agreed diagnosis in four of these. The proliferation fraction (Ki67) in the 10 
cases tested was 2.1% ± 0.18. These indings illustrate the diagnostic challenges in this group of tumors and highlight the 
gaps in knowledge. Techniques, such as EWSR1 gene cytogenetic analysis, may be helpful in cases with clear cells. However, 
in other areas of controversy, including the non-calcifying and Langerhans cell rich variants, further investigation, perhaps 
utilizing sequencing technologies may be needed to reine the classiication. Owing to the relative rarity of these lesions it 
would be beneicial if future work could be pursued as an international collaboration.
Keywords Odontogenic · Tumor · CEOT · Calcifying epithelial odontogenic tumor · Clear cell · Amyloid · EWSR1
Introduction and Review of the Literature
Jens Pindborg described the calcifying epithelial odonto-
genic tumor (CEOT), a rare epithelial odontogenic tumor, 
in detail in 1958 [1]. Many authorities suggest, however, 
that the irst description was by Thoma and Goldman ten 
years previously, who termed it adenoid-type adamantoblas-
toma [2], although earlier descriptions do exist [3]. Vari-
ous synonyms have been used to describe this lesion, such 
as adamantoblastoma [4], ameloblastoma of unusual type 
with calciication [5], malignant odontoma [6], and cystic 
complex odontoma [7]. In 1963, the term ‘Pindborg tumor’ 
was irst used by Shafer and this is a well-recognized epo-
nym for this neoplasm [8]. Twenty years after the original 
CEOT description, Pindborg and Franklin reviewed 113 
cases reported in the literature [9].
Since the original descriptions, the number of cases has 
continued to increase and, to date, more than 362 cases have 
been reported [10]. According to this recent review of pub-
lished cases, there was an almost equal distribution among 
males and females and the peak age of occurrence of central 
lesions was in the 3rd and 4th decades, similar to that pre-
sented in our recent series of odontogenic tumors [11]. The 
majority occurred in the body of the mandible, but some 
were large lesions, extending widely antero-posteriorly and 
involving the ramus [10, 11]. Most presentations are intra-
osseous but in 1966, Pindborg described an extra-osseous/
peripheral CEOT [12].
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Radiologically, CEOTs vary from small, unilocular radio-
lucent lesions to extensive multilocular, mixed radio-dense 
lesions often associated with an impacted tooth (in 61% of 
central cases [10]). Some authors have considered the pres-
ence of radio-opaque lecks in the pericoronal tissues of an 
impacted tooth (as originally described by Pindborg) as char-
acteristic for CEOT [13]. Half of the central lesions show 
evidence of cortical bone perforation whilst 40% of periph-
eral CEOTs have subjacent bone erosion [10]. On Computed 
tomography (CT) scans, there is difuse high attenuation, 
suggesting calciication and/or ossiication. On magnetic 
resonance imaging (MRI), CEOT is a hypointense tumor 
on T1-weighted images and a mixed hyper intense tumor on 
T2-weighted images [14]. CT scans and 3D reconstructions 
may be useful in delineating the extent of the lesion, which 
is essential for surgical treatment planning [15]. Whilst 
CEOT is considered a benign epithelial neoplasm, evidence 
of clinically aggressive behavior, malignant transformation 
with multiple recurrences and cases with metastasis have 
been reported [10, 16].
The histological hallmarks of the “classic” CEOT are 
sheets of polyhedral epithelial cells with distinct cell bor-
ders, prominent intercellular bridges, nuclear pleomorphism, 
and few mitoses (Fig. 1) [1, 9, 12]. Also common are con-
centric calciications (Liesegang rings) and the presence of 
deposits of amorphous ‘amyloid-like’ eosinophilic material 
which stains with Congo Red (Fig. 2) and demonstrates 
apple-green birefringence on polarization. This material is 
largely PAS negative prior to calciication [9].
It has been suggested that CEOTs originate from remnants 
of the dental lamina [17] or stratum intermedium [18]. Two 
cell types have been demonstrated by electron microscopy: 
polyhedral epithelial cells and myoepithelial-like cells con-
taining electron-dense tonoilament bundles, electron-dense 
Fig. 1  Photomicrograph illus-
trating the histological features 
described the original publica-
tion by Pindborg [1]
Fig. 2  Photomicrograph of the 
characteristic appearance of 
CEOT amyloid, as stained by 
Congo Red (a)
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bodies, and ine lamina dense ilaments [19]. Immunohisto-
chemically, the polyhedral cells of CEOT express laminins 
1 and 5, cytokeratins, ibronectin and vimentin [20]. High 
levels of alkaline phosphatase and ATPase localization to 
the cell membrane are signiicant indings [21]. The amyloid 
material has been shown to contain a number of ameloblast 
associated proteins, most consistently Odontogenic Amelo-
blast-Associated Protein (ODAM) [22].
Apart from the classic features, a number of CEOT vari-
ants have been reported, with various proportions of clear 
cells, Langerhans cells and some cases without calciication. 
Furthermore, hybrid tumors with adenomatoid odontogenic 
tumor or ameloblastoma [10, 23, 24], and cystic/microcystic 
variants have been reported [25, 26]. Ai-Ru et al. proposed a 
sub-classiication comprising four histological patterns, indi-
cating that some tumors might show a cribriform appearance 
without clear cell borders; others may contain multinucle-
ated giant cells or cells with abundant eosinophilic cyto-
plasm or clear/vacuolated cells with centrally placed nuclei 
[27]. However, this sub-classiication was based on only nine 
cases and has not been widely adopted or otherwise assessed 
in a larger study population.
In this case series, we aimed to review all of our diagno-
ses of CEOT in the diagnostic archive (either deinitive or in 
diferential diagnosis) and review them in light of the three 
WHO classiications published during this time (1991, 2005 
and 2017) and the current literature on this entity.
Materials and Methods
The diagnostic database of the department of Oral and Max-
illofacial Pathology, Charles Cliford Dental Hospital/School 
of Clinical Dentistry, University of Sheield, was searched 
for cases either with the diagnostic code of CEOT (as a 
deinitive diagnosis) or by keyword search where CEOT 
was raised as a diferential diagnosis in more challenging 
cases from 1975 to 2017. Clinical information including age, 
gender and location of the tumor were recorded, and plain 
ilm radiology was reviewed where available. Very limited 
clinical follow-up data was available, and none of the cases 
for which this was available recurred.
Given the passage of time since the original diagnoses in 
the series (a span of 42 years: and three intervening WHO 
classiications), the original slides were re-evaluated using 
contemporary diagnostic criteria, with attention to the 2017 
WHO classiication of odontogenic lesions [28]. Hematoxy-
lin and Eosin and Congo Red stained sections of the selected 
cases from the database were re-evaluated by 3 experienced 
OMF Pathologists (PMS, KDH and SAK), and consensus 
diagnoses recorded. Cases with multiple biopsies (incisional 
and resection) were considered as single cases.
Immunohistochemical analysis of the expression of Ki67 
(Rabbit polyclonal Abcam ab16667 at 1:50; to assess the 
proliferation fraction) and Amelogenin/AMELX (Rabbit 
monoclonal, Abcam ab129418 at 1:150; to assess ameloblas-
tic diferentiation) was conducted on 10 and 8 cases respec-
tively, where suicient formalin ixed parain embedded 
(FFPE) material remained. Slides were dewaxed and rehy-
drated before quenching of endogenous peroxidase using 
 H2O2. Heat-induced epitope retrieval in 0.01 M sodium cit-
rate was undertaken before blocking with normal serum. 
After primary antibody incubation, biotinylated secondary 
antibodies were used and speciic staining demonstrated 
using the Vector Nova Red kit (Vector Laboratories Inc, 
Burlingame, CA, USA). Ki67 was assessed as % of cells 
positive and AMELX expression was assessed using a modi-
ied quickscore method [29], with a maximum possible score 
of 24.
Results
Thirty two cases had been coded as CEOT in the diagnostic 
database from 1975 to 2017. Histological slides (H&E and 
Congo Red) were available for 26 cases (Table 1). In one 
additional case, whilst a diferential diagnosis of CEOT was 
suggested in the incisional biopsy, the resection showed an 
unequivocally malignant odontogenic tumor. This case was 
excluded. A variety of other histochemical (largely PAS) and 
immunohistochemical stains were available in some cases, 
conducted as part of the original diagnostic work-up. Of 
the 26 cases, 18 were referral/consult cases, so the FFPE 
blocks were not available for further analysis. In 15 cases, a 
deinitive diagnosis of CEOT had been made, whilst in the 
remaining 11, it was part of a diferential diagnosis.
The age range was 23–74  years with a mean age of 
42 ± 2.6 (Table 1). There was an equal gender distribu-
tion. 62% occurred in the mandible and, of the mandibular 
tumors, the majority were in the posterior mandible (54%). 
Of those in the maxilla, 3/10 (30%) involved the maxillary 
sinus. The majority of CEOTs were intraosseous (18/26; 
69%), whilst 8 were peripheral lesions (31%). Association 
with unerupted teeth was not consistently recorded.
Histologically, a variety of appearances were seen 
and many cases met the criteria for diagnosis originally 
described by Pindborg (13/26; 50%), but a number of other 
histological appearances were also observed. Clear cell clus-
ters (of varying extent) were observed in 46% (12/26), more 
commonly in peripheral tumors (6/8; 75%). Out of the total 
sample, 10 cases had no identiiable calciications (Table 2). 
Three of the cases (7, 24 and 26) contained dentin-like mate-
rial (dentinoid).
The relationship of the review diagnoses to the origi-
nal diagnoses is presented in Table 2. Of the 26 cases, 14 
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were conirmed as CEOT (12 “classic” CEOT, and 2 of 
the clear cell variant of CEOT). In 6 cases, CEOT was 
part of a diferential diagnosis, which variably included 
central odontogenic ibroma, clear cell odontogenic car-
cinoma (CCOC), sclerosing odontogenic carcinoma and 
odontogenic carcinoma with dentinoid. In two cases, other 
diagnoses were favored (one clear cell odontogenic carci-
noma, and one ameloblastoma with clear cells), and four 
were odontogenic tumors which were diicult to classify 
with no consensus achieved.
Immunohistochemistry for Ki67 expression was avail-
able for 10 of the cases with a mean of 2.1% of positive 
cells (SEM = 0.18; range 1–6%; Fig. 3a). This reinforces 
the concept that despite frequent nuclear and pleomor-
phism, the proliferation rate is low. There was no discern-
ible pattern of ki67 expression with regard to histological 
subtype, nor in those cases where a malignant diagnosis 
was considered. The lowest (1%) and highest (6%) Ki67 
expression were both found in “classic” subtypes. AMELX 
(amelogenin) was expressed in the epithelium in all 8 
cases tested, with the histoscore varying between 5 and 
18 (Fig. 3b), indicating that this may be of use, similar to 
ODAM, in demonstrating ameloblastic diferentiation in 
the epithelial cells.
Discussion
A summary of the main histological variants of CEOT, 
which have been described in the literature, is presented 
in Table 3 and a summary of the histochemical and immu-
nohistochemical staining characteristics of these diferent 
cell types is presented in Table 4. In addition to these main 
variants, others, such as melanin-containing lesions have 
also been described [24, 30]. The reported variation in 
clinical outcomes may represent a spectrum of biological 
behavior in CEOT, but conversely may merely represent 
a group of heterogeneous entities which have, for various 
reasons discussed below, been classiied together as “vari-
ants” of CEOT, which are briely reviewed below.
Table 1  Demographic and 
histological data of the cohort 
of 26 CEOTs
Dx diagnosis
Case no Year of Dx Age Sex Site Central/peripheral
1 1975 32 Male Not known Central
2 1978 38 Female Not known Central
3 1980 50 Female Not known Peripheral
4 1982 38 Male Mid Mandible Central
5 1988 25 Male Mid to post mandible Peripheral
6 1992 23 Male Ant to mid maxilla Peripheral
7 1993 39 Female Mid to post mandible Central
8 1993 31 Female Ant to mid mandible Central
9 1997 44 Male Mid to post mandible Central
10 1998 52 Male Mid mandible Central
11 1999 49 Female Mid maxilla Central
12 2003 32 Female Ant mandible Peripheral
13 2004 69 Female Mid maxilla Central
14 2004 25 Male Maxillary antrum Central
15 2007 48 Female Post mandible Central
16 2008 53 Male Maxillary antrum Central
17 2009 30 Male Post maxilla Central
18 2010 47 Male Mid to post mandible Peripheral
19 2010 27 Female Ant to mid mandible Peripheral
20 2011 46 Male Mid to post maxilla Central
21 2011 49 Male Mid to post mandible Central
22 2012 74 Female Ramus of mandible Central
23 2013 52 Male Mid Mandible Central
24 2015 32 Female Ant maxilla Peripheral
25 2015 55 Female Maxillary antrum Central
26 2016 34 Female Maxillary antrum Peripheral
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Table 2  Histological features of the cohort of 26 CEOTs
Case no Epithelium 
description
Distinct 
cellular 
outline
Prominent 
intercellular 
bridges
Eosino-
philic 
cytoplasm
Nuclear/cel-
lular pleomor-
phism
Mitotic 
igures
Calciications/ 
Liesegang 
rings
Amyloid Clear cells Original diagnosis Review consensus 
diagnosis
IHC
1 Nests Y Y Y Y N Y Y N Typical CEOT CEOT
2 Nests Y N Y Y N N Y N Typical CEOT CEOT ki67 6%
3 Small nests and 
thin strands
Y N Y Y N N Y Y (focal) Unusual, maybe 
CEOT or OD 
hamartoma
CEOT vs OdF
4 Nests Y Y Y Y N Y Y N Typical CEOT CEOT
5 Small nests and 
thin strands
N N Y Y N Y (focal) N Y (focal) Unusual, CEOT 
(preferred) vs 
OdF
CEOT vs CCOC ki67 5%
6 Small nests and 
thin strands
Y N Y Y N N Y Y (focal) CEOT CEOT vs OdF
7 Sheets and thin 
strands
Y N Y Y N Y* N Y CEOT, clear cell 
variant
No consensus ki67 < 1%
8 Sheets and small 
nests
Y Y Y Y N Y Y N Typical CEOT CEOT ki67 2%
9 Sheets and thin 
strands
N N Y Y N N Y N Unusual OT, 
CEOT vs OF
No consensus
10 Sheets and thin 
strands
Y N Y Y N Y Y Y (focal) CEOT CEOT, clear cell 
variant
ki67 < 1%
11 Small nests and 
thin strands
Y N Y Y N N Y N CEOT CEOT vs OdF/
SOC
ki67 2%
12 Small nests and 
thin strands
Y Y N Y N Y Y Y CEOT CEOT
13 Small nests Y N Y Y N Y
(min)
Y Y CEOT CEOT ki67 < 1%
14 Small nests Y Y Y Y N Y Y Y (focal) CEOT, maybe 
arising from 
dentigerous cyst
CEOT ki67 1%
15 Small nests Y Y Y Y N Y Y N Typical CEOT CEOT
16 Sheets and thin 
strands
Y N Y Y N N N Y Unusual, maybe 
CEOT variant
Ameloblastoma 
with clear cells
17 Small nests and 
thin strands
Y Few ? Y N N N N Unusual, perhaps 
non-calcifying 
CEOT
No consensus
18 Small nests and 
thin strands
Y In some areas Y Y N Y Equiv Y (most) Clear cell CEOT CEOT, clear cell 
variant
19 Small nests and 
thin strands
Y Y Y Y N N Y N CEOT CEOT
20 Small nests Y
(few)
N Y Y N Y
(few)
Y Y (focal) CEOT CEOT vs OdF
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Clear Cell Variant
In 1967, Abrams and Howell described the irst case of a 
CEOT with a clear cell component [31]. Many case reports 
and series have followed, some of which are summarized 
in Table 3. Most of the clear cell CEOTs are intraosseous 
lesions and are most commonly found in the mandible [10]. 
The mean age is 44 years, which is 8 years older than for 
conventional CEOT. Unlike conventional CEOT, there is a 
female predilection and an association with unerupted teeth 
was found in only six out of the 24 patients, compared with 
nearly 50% of the conventional CEOTs. It has been sug-
gested that clear cell CEOTs are clinically more aggressive 
as they tend to perforate the cortex and recur more frequently 
than other CEOT variants [32–34].
In almost all the reported cases, there were areas with 
histological features of conventional CEOT including poly-
hedral sheets of epithelial cells with prominent intercellular 
bridges, amyloid-like material and calciications. The clear 
cells contain PAS positive material which is diastase labile, O
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Fig. 3  Photomicrograph of Ki67 (a) and AMELX expression (b) in a 
selected CEOT case from the cohort
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Table 3  A summary of reported cases and case series of variants of CEOT
Authors Age/sex Location Radiographic features Histopathological indings C/P
CEOT cystic variant
Gopalakrishnan et al. [26] 15M Left posterior maxilla Unilocular radiolucency with radiopacities Cyst lining varying from NKSSE to thick-
ened epithelium with characteristics of 
CEOT
C
Channappa et al. [48] 30M Left posterior maxilla Unilocular radiolucency with calciications in 
association with impacted tooth #13
Cyst lined by odontogenic epithelium, major-
ity with uniform thickness, with classic 
features of CEOT
C
Urias Barreras et al. [49] 31M Left Posterior mandible Unilocular radiopaque/lucent area Lining of odontogenic epithelium with 
necrosis, featuring clear cells (PASD posi-
tive and osteodentin
C
Dantas et al. [50] 22M Right posterior mandible Unilocular, mixed radiodensity lesion, root 
resorption
Microcystic lined by typical CEOT with 
abundant clear cells
C
Sánchez-Romero et al. [25] 42F Right posterior mandible Well-deined mixed radiodense lesion in rela-
tion to an un-erupted third molar
Microcystic compartments of varying size 
and occasional clear cells with classic 
features of CEOT
C
CEOT clear cell variant
Abrams and Howell [31] 50M Posterior mandible Unilocular mixed radiodense/radiolucent Prominent clear cells with classic features of 
CEOT
C
Anderson et al. [37] 68F Left mandible molar area Unilocular radiolucent/radiopacity Prominent clear cells with classic features of 
CEOT
C
Oikarinen et al. [59] 36F Mandible Left molar to right premolar Multiloculated radiolucent with radiopaque 
central region
Prominent clear cells with classic features of 
CEOT. Amyloid diagnosed under electron 
microscopy
C
Yamaguchi et al. [60] 36M Right mandible from anterior to premolar 
region
Unilocular radiolucency Prominent clear cells with classic features of 
CEOT. PAS positive granules in clear cells
C
Ai-Ru et al. [27] 64F Anterior mandible Not recorded Prominent clear cells with classic features of 
CEOT
C
Asano et al. [43] 44F Right maxilla Unilocular, radiolucent area with root resorp-
tion
Islands that frequently contained clear cells 
with typical features of CEOT
C
Schmidt-Westhausen et al. [36] 38M Right premolar to left incisor region in 
mandible
Radiolucency with difuse radiopacities in 
part of the lesion
Central necrosis of large epithelial islands 
and clusters of clear cells
C
Hicks et al. [61] 59F Right posterior mandible Unilocular mixed radiolucency and radiopac-
ity
Prominent clear cells with classic features of 
CEOT
C
Kumamoto et al. [62] 14F Right maxillary 3rd molar region Unilocular radiolucency impacted upper right 
3rd molar
Prominent clear cells, few mitotic igures and 
typical features of CEOT
C
Anavi et al. [33] 27M Left mandibular canine and irst premolar Unilocular well-circumscribed radiolucency Sheets of clear cells, amyloid and few small 
oval calciications
C
Germanier et al. [63] 44F Right angle of the mandible enclosing the 
3rd molar
Multiloculated radiolucency with calciica-
tions
Clear cells in some places and with typical 
CEOT
C
Mohtasham et al. [64] 18M Right anterior maxilla Radiolucency with calciication Scattered clear cells with typical features of 
CEOT
C
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Table 3  (continued)
Authors Age/sex Location Radiographic features Histopathological indings C/P
Rangel et al. [32] 65M Right mandible between lateral incisor and 
canine
Unilocular radiolucency with radio-opacities Signiicant portion of cells are clear and 
other areas with typical features of CEOT
C
Sahni et al. [65] 52M Right maxilla Mixed radiodensity lesion Areas of clear cells within epithelial islands 
and with typical features of CEOT
C
Chen et al. [66] 59F Posterior mandible/ ramus Unilocular radiolucency Nests of clear cells in a pseudoglandular 
pattern. Other areas with typical features 
of CEOT
C
Turatti et al [67] 25F Left mandible Unilocular radiolucency with root displace-
ment
Sheets and nests of clear cells with areas of 
calciications and amyloid
C
Rydin et al. [68] 40F Left mandible Unilocular radiolucency with scattered 
calciications
Central portion of the tumor composed 
of clear cells and periphery with typical 
CEOT
C
Chatterjee et al. [69] 73F Left maxillary molar region A large mixed radiodense/RL area spearing 
maxillary antrum
Typical CEOT with Clear cells. PAS positive C
Sabir et al. [70] 63F Angle of the mandible Radiolucent lesion in ramus distal to 3rd 
molar
Almost all islands are clear cells amyloid in 
between
C
Júnior et al. [71] 42M Mandibular symphysial region Unilocular radiolucency with patchy radio 
density
Most clusters with clear cells and abundant 
small calciications and amyloid
C
Wertheimer et al. [35] 20M Right maxillary gingiva Premolar region cup-shaped area Typical areas of CEOT with some areas with 
clear cells
P
Ai-Ru et al. [27] 32F
47F
mandibular gingiva No signs of bone involvement Typical areas of CEOT with some areas with 
clusters of clear cells
P
Houston and Fowler [72] 27M Gingiva of right posterior mandible Underlying bone was normal Prominent clear cells with classic features of 
CEOT
P
Orsini et al. [73] 32M Maxillary gingiva NA Typical areas of CEOT with some areas with 
clusters of clear cells
P
Mesquita et al. [74] 48F Right maxilla, canine region NA Polyhedral and clear epithelial cells associ-
ated with amyloid-like deposition
P
Anavi et al. [33] 27M Left mandible Alveolar crest resorption Sheets of clear cells, focal mild atypia with 
amyloid in between cells and clusters
P
de Oliveira et al. [75] 43F Lesion 1: Left mandible
Lesion 2: Left maxilla
Supericial cupping in canine area some clusters are composed with clear cells 
with typical features of CEOT
P
Habibi et al. [76] 70F Left maxilla Normal underlying alveolar bone Typical areas of CEOT with some areas with 
clusters of clear cells
P
Gadodia et al. [77] 18M Left mandible Alveolar crest resorption Scattered clear cells with classic features of 
CEOT
P
CEOT Non-calcified with Langerhans cells
Asano et al. [43] 44F Right maxilla Unilocular radiolucency Less cellular, clear cells within polyhedral 
cell clusters. Birbeck granules seen. No 
calciication
C
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Table 3  (continued)
Authors Age/sex Location Radiographic features Histopathological indings C/P
Takata et al. [44] 58M Left maxillary canine premolar region Unilocular radiolucency Scattered small islands of epithelial cells. 
Within islands many spherical bodies seen. 
Amyloid present. S-100 positive. Birbeck 
granules identiied
C
Wang et al. [78] 52F Right maxilla, central incisor canine region Unilocular radiolucency Small nests of polyhedral cells and amyloid 
deposition. Clear cells present. CD1a posi-
tive cells are frequent. No calciication
C
Wang et al. [79] 38M
39F
Right mandible
Left maxilla
Unilocular radiolucency with patchy radi-
opacities
Small nests and cords of epithelial cells. 
Few clear cells. Amyloid present. CD1a + , 
Birbeck granules identiied. No calciica-
tion
C
P
Afroz et al. [40] 20F Right maxilla, lateral incisor area Normal underlying alveolar bone Scattered small islands of polygonal cells and 
occasional clear cells. Amyloid present. 
No calciications. Clear cells conirmed as 
Langerhans cells (S100)
P
Chen et al. [45] 40F
58M
Maxilla Unilocular radiolucency with root resorption
Multilocular radiolucency with root resorp-
tion
Small nests and cords of epithelial islands 
with some clear cells. Amyloid present, 
CD1a + , langerin + , No calciication
Both C
Tseng et al. [80] 24M Left maxilla, canine premolar area Unilocular radiolucency with root resorption 
in canine and premolar
Strands and island of epithelial cells and 
some clear cells. Scant amyloid, CD1a + , 
No calciication
C
Santosh et al. [81] 44M Left anterior maxilla Large unilocular radiolucency Bland epithelial islands with admixed 
amyloid. CD1a + cells. No calciication was 
present
C
Combined epithelial odontogenic tumor. CEOT /AOT
Damm et al. [18] 18M
15F
Mandible Unilocular predominantly radiolucent, one 
case with radiopacities
A cystic tumor lined with areas of typical 
AOT. And some CEOT-like areas
C
Bingham et al. [82] 14F Right mandible Unilocular radiolucent lesion related to 
impacted irst premolar tooth
Cystic tumor with multiple intraluminal 
nodules. Some typical AOT and others are 
CEOT. Amyloid positive. Calciications 
noted
C
Takeda and Kudo [83] 17F Right maxilla between incisors Unilocular radiolucent lesion with lakes of 
radio densities
Encapsulated solid tumor with areas of typi-
cal AOT and CEOT. Amyloid positive
C
Siar and Ng [51] 13–28
2M, 3F
3 in maxilla, 2 in mandible Radiolucent lesion Thick walled cystic tumor lined with areas 
of typical AOT and variable amounts of 
CEOT-like areas
All C
Ledesma et al. [84] 10–21
10F, 2M
9 in maxilla (most canine region), 2 mandible Radiolucent lesion most related to impacted 
canine tooth. Some have radiopacities
Typical AOT areas with CEOT-like areas of 
variable sizes
11 C
1 P
Miyake et al. [85] 16F Left maxilla, canine region Radiolucent lesion related to impacted canine 
tooth
Encapsulated solid tumor composed with 
areas of typical AOT and CEOT. Amyloid 
positive
C
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consistent with glycogen, and does not stain with Alcian 
Blue [35]. This inding is consistent with suggestions that 
the clear cells form by epithelial cell degradation [36, 37]. 
Although the presence of typical areas of conventional 
CEOT, with minor cellular atypia and absence of mitoses 
helps in diagnosis, special stains and cytogenetics may be 
helpful in arriving at a inal diagnosis. CEOTs with promi-
nent clear cells must be diagnosed with caution, as many 
clear cell neoplasms are malignant and further investigations 
are needed to exclude clear cell malignancies such as CCOC 
and other carcinomas with a clear cell component (for exam-
ple, of renal or salivary origin) [38]. It is unclear to what 
extent diiculties in distinguishing clear cell CEOTs from 
CCOC has contributed to the reported apparent increased 
aggressiveness of clear cell CEOT.
Non‑Calciied and Langerhans Cell‑Rich Variants 
of CEOT
The non-calciied variant of CEOT is the least reported 
variant (Table 3). To date, eight intraosseous cases and 
two extraosseous cases of non-calciied CEOT have been 
reported [39, 40]. The absence of calciication in CEOT 
may be due to the relative immaturity of the lesion, as long-
standing tumors tend to have more calciications than young, 
underdeveloped ones [41]. In a study of 19 patients with 
CEOT by Azevedo et al., the age of patients at the time of 
diagnosis was linked to the amount of calciication; older 
patients showing more calciications [42]. This variant of 
CEOT usually appears as a radiolucent area on radiographs 
that may be misdiagnosed as an odontogenic cyst.
Many of these cases contain Langerhans cells (LC), 
which are antigen-presenting immune cells that are normally 
found in oral epithelium but have also been described in 
conventional CEOT in small numbers. If abundant, LC-rich 
lesions are considered a variant of CEOT [43, 44]. They 
appear histologically as clear cells, which contain Birbeck 
granules, within the tumor’s conventional pattern of poly-
hedral sheets of epithelial cells and amyloid-like material. 
Five of the cases reported so far were without associated 
calciication, all of whom presented in patients of Asian 
origin [45]. However, a Langerhans cell–rich case with cal-
ciication has been reported in one black individual [46], 
challenging the concept that ‘all CEOTs with a Langerhans 
cell component are non-calciied variants’. Diagnosis of this 
variant is based on either electron microscopic examination 
of the LC structure or positive staining of LCs for S100 and 
CD1a [46]. The natural history of this variant is not well 
described.
Histological examination was important in all of the 
reported cases of non-calciied CEOT, in order to evalu-
ate the presence of the classic features of epithelial sheets 
and amyloid-like material. In one reported case there was Ta
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a “poorly diferentiated non-calciied CEOT” [41]. Others 
contained Langerhans cells. Takata et al. reported a case 
with a histologic appearance consistent with “pattern four” 
in the Ai-Ru subtypes of conventional CEOT [44]. It was 
suggested by Kaushal et al. that the non-calciied variant 
of CEOT behaves more aggressively than calciied CEOTs 
[39]. However, this contrasted with suggestions made in 
previous studies that most non-calciied CEOTs contain 
Langerhans cells, which may indicate a less aggressive 
lesion. More research in non-calciied CEOT cases with 
and without LCs is required to address this issue. There has 
been recent discussion regarding the nature of these non-
calcifying, Langerhans cell-rich lesions [47]. This issue will 
be explored further later.
Cystic/Microcystic Variant
Recently, a number of reports of cystic and microcystic vari-
ants of CEOT have been published. The initial report was 
of a large cystic lesion in a 15 year-old male, in which the 
lining demonstrated CEOT features [26]. The lesion was 
enucleated. A number of similar cases have been reported 
[48–50], and subsequently, a microcystic variant has also 
been described [25]. In this lesion, a pseudo-glandular 
appearance was reported in association with otherwise rather 
conventional CEOT histology. The natural history of these 
lesions is not known, but there have been no reports of recur-
rences so far.
Table 4  Histochemical and immunohistochemical stains in CEOT
The information has been gathered from references [9, 20–22, 35, 67, 87, 42]
a If not calciied
Epithelial cells Amyloid- like 
material
Calciication Clear cells Langerhans cell Stromal cells
Histochemical stains
 Congo red ᪧ
 Thiolavin T ᪧ
 PAS ᪧa
 Tryptophan ᪧ
IHC stains
 Pan-cytokeratin ᪧ ᪧ
 Cytokeratin cocktail ᪧ
 EGFR ᪧ
 p63 ᪧ ᪧ
 CK7 ᪧ ᪧ
 CK14 ᪧ ᪧ
 CK8 ᪧ ᪧ
 CK13 ᪧ ᪧ
 CK19 ᪧ ᪧ
 Vimentin ᪧ
 Ameloblast-associated protein ᪧ ᪧ ᪧ
 Amelotin ᪧ
 Ameloblastin ᪧ
 Amelogenin ᪧ ᪧ
 S100 protein ᪧ
 CD1a ᪧ
 Langerin ᪧ
 Enamelin ᪧ
 Syndecan-1
(CD138)
ᪧ ᪧ ᪧ
 E-Cadherin ᪧ
 Amyloid A ᪧ ᪧ ᪧ
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Combined CEOT‑Adenomatoid Odontogenic Tumor
Although it is not a variant of CEOT, Adenomatoid odonto-
genic tumor (AOT) is worth mentioning in this context, as 
some contain CEOT-like areas. AOT is a separate odonto-
genic tumor with its own distinctive histological features. In 
1983 Damm et al. reported an AOT that contained CEOT-
like features and named it ‘combined epithelial odontogenic 
tumor’ [18]. Philipsen and Reichart reported 24 AOTs 
with some areas of CEOT-like components [23]. None of 
these combined AOTs /CEOT were dominated by CEOT-
like areas. According to Ng and Siar, the behavior of these 
forms of AOT was no diferent from that of the conventional 
AOT and suggested they were benign hamartomas without 
any evidence of CEOT-like aggressive behavior, and none 
recurred [51]. Thus, combined CEOT-AOTs should be man-
aged as conventional AOTs.
The designation of these cases as variants of CEOT has 
resulted in a dramatic widening of the histological spectrum 
of appearances that fall under the diagnostic umbrella of 
CEOT, far beyond the original histological description [1]. 
Furthermore, there are some odontogenic tumors that do 
not it very well into the diagnostic criteria of the existing 
classiication. This includes a number of lesions containing 
dentinoid and dispersed nests of tumor cells within a hyalin-
ized stroma, which can share some histological features of 
CEOT. This raises an important issue as to the usefulness of 
tumor sub-classiications that develop incrementally, without 
periodic review of the variations in histological appearances 
in other tumors and integration of new insights from other 
molecular features including genomic analyses. It also raises 
questions regarding the usefulness of historical surveys of 
variants of this tumor, as, given progress in knowledge of the 
biology of odontogenic tumors, some variants which have 
been labelled as part of the CEOT family, may not be so.
In the present report, 26 sequentially accessioned cases 
from a single Oral and Maxillofacial Pathology Diagnostic 
Service from 1975 to 2017 have been analyzed. In these 
cases, diverse histomorphology was seen, but the index diag-
nosis was of a CEOT, or CEOT was included in the diferen-
tial diagnosis. The whole cohort has been reviewed taking 
into account a number of other entities which have been 
described since the original diagnoses were made, particu-
larly those in the early years of the cohort. In one case the 
resection specimen showed an odontogenic malignancy, with 
necrosis, a high mitotic rate and areas of de-diferentiation. 
We excluded this as there was limited evidence of CEOT in 
the biopsy or resection. However, this does raise the issue of 
malignant CEOT, which we did not identify in the review of 
our diagnostic archive. A small number of individual case 
reports have been published, most of which show areas of 
conventional CEOT with associated malignant transforma-
tion [16, 52]. A detailed discussion of diagnostic features is 
beyond the scope of this review, however, as with ameloblas-
tic carcinoma, this is fraught with diiculty. A combination 
of the use of a proliferation marker, such as Ki67, with his-
tological features of malignancy may be useful, but this has 
not been assessed in a cohort of these lesions.
In our cohort, the “classic” appearance, as described in 
the initial Pindborg paper [1], was found in only 13/26 cases 
(50%). In our series, we deined this as a tumor demonstrat-
ing the described epithelial features (polyhedral cells with 
clear boundaries), and containing amyloid, in keeping with 
the WHO 2017 classiication [28]. Other features, such as 
calciication and nuclear pleomorphism were variably pre-
sent. Tumors with these histological features present little 
diiculty in diagnosis. Two other tumors were diagnosed 
as clear cell CEOT as, although they were dominated by a 
clear cell population, they also contained areas of “classic” 
CEOT, with amyloid.
The main diferential diagnosis to be considered in the 
tumors with a signiicant clear cell component is Clear Cell 
Odontogenic Carcinoma (CCOC). CCOC is an intraosseous 
malignant neoplasm consisting of sheets, nests and cords of 
polygonal to round clear cells, usually separated by ibrous 
septa and often showing peripheral palisading [53]. The 
lesional clear cells are usually PAS positive, diastase sen-
sitive and negative for mucicarmine (mucin). Congo Red 
(amyloid) is also negative. Histologically, CC-CEOTs that 
contain few epithelial islands with clear cells in an eosino-
philic homogenous stroma need careful investigations in 
order to conirm them as CEOT. It is mandatory to identify 
the presence of amyloid for conirmation. Metastatic tumors 
that contain clear cells are most likely renal cell carcinoma, 
clear cell breast carcinoma or thyroid carcinoma and, there-
fore, immunomarkers such as RCC, CD10, PAX8, ER/PR, 
TTF-1 are useful [54].
In diicult cases or small biopsies, luorescence in situ 
hybridization (FISH) for EWSR1 gene rearrangement can 
be used to resolve this dilemma. EWSR1 gene rearrange-
ment is absent in CEOT, clearly separating CC-CEOT 
from CCOC. Bilodeau et  al. analyzed 12 CCCa and 8 
CCOCs for EWSR-ATF1 FISH with 92% and 63% posi-
tive respectively. Subsequent Congo Red staining revealed 
that two of the CCOC that were negative for EWSR1 rear-
rangement contained amyloid; therefore these were more 
likely to be hypocellular CEOTs rather than CCOC with 
hyalinized stroma [55]. A key element in this analysis is 
the availability of tissue which has not been decalciied. 
Unfortunately, a combination of unavailability of FFPE 
blocks, very old tissue and a high frequency of decalcii-
cation in our cohort meant that EWRSR1 rearrangement 
studies were either not possible, or failed, in our cohort.
In cases where a diferential diagnosis was agreed after 
review, four included odontogenic ibroma (OdF) and scle-
rosing odontogenic carcinoma as diferential diagnoses. 
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On H&E, these cases resemble “pattern 4” in the subtypes 
described by Ai-Ru et al. [27], with dominance of a ibrous 
stroma component. The diiculties in distinguishing these 
entities have been recently discussed in the literature and 
are very relevant to addressing the issues of the uncer-
tain nature of the non-calcifying CEOT variants. As high-
lighted recently by Ide et al. [47], diferential diagnosis 
of odontogenic ibroma (OdF) has been raised in these 
lesions and, indeed, there is much to suggest (including a 
lack of recurrence) that they may represent odontogenic 
ibromas, rather than non-calcifying CEOTs. This is rein-
forced in the case series reported by Eversole [56], where 
a small number of the 65 OdFs described contained both 
ODAM positive amyloid and Langerhans cells. It is worth 
noting that this issue was raised in the 1971 WHO clas-
siication, in relation to the diferential diagnosis of non-
calcifying CEOT and cellular OdF [57].
We considered sclerosing odontogenic carcinoma as a 
diferential diagnosis in some cases (Table 1). This tumor 
has now been added to the WHO classiication [28], but 
is somewhat controversial, and clear diagnostic criteria 
have not been established. Perineural invasion was not 
seen in any of these cases where this was considered as a 
diagnosis.
Three of these cases contained dentinoid. The signii-
cance of this is unclear, but in two cases, we included 
odontogenic carcinoma with dentinoid in the diferential 
diagnosis, as these tumors presented some features similar 
to the case reports of this entity [58]. In particular, this 
was considered in cases where the original diagnosis was 
rather uncertain, where CEOT was a suggested diagnosis 
whilst acknowledging the tumor was diicult to classify. 
This indicates that the classiication, and what may be con-
sidered to fall within the diagnostic remit of CEOT, may 
further evolve as other odontogenic entities are described 
and their diagnostic criteria established.
Conclusion
The development of diagnostic criteria for a tumor is an 
iterative process and the description and acceptance of 
tumor variants is limited to some degree by the lack of 
appropriate molecular tools to conirm or refute the plac-
ing of a particular tumor into its place on the classiica-
tion. The description of a number of the variants of CEOT 
very much falls into this trap. Whilst some of the vari-
ants are most likely true variants of CEOT, it is becoming 
increasingly apparent that others are most likely a part of 
the spectrum of other odontogenic entities. This includes 
CCOC (now with EWSR1 cytogenetics to aid diagnosis) 
and odontogenic ibroma. Further reinement will most 
likely require a collaborative international approach to col-
lect suiciently large cohorts of these cases allow a more 
comprehensive molecular characterization of this group of 
lesions. In this way, more variants may be deined as other 
entities, whilst the true spectrum of CEOT is established. 
Such analysis may also aid in deining the histogenesis of 
these lesions.
This will not be without its challenges: many of the cases 
of CEOT are decalciied, which may signiicantly com-
promise the quality of genomic information which can be 
obtained from these specimens. To this end, careful con-
sideration will have to be given to a concerted international 
efort to collect samples which have been optimally col-
lected, stored and processed. The development of an inter-
national prospective database, with associated availability of 
both ixed and fresh material, which has not undergone harsh 
decalciication will be needed, and this could be coordinated 
via various international specialist societies. This will then 
allow for a program of translational research, which can 
include multi-omics analyses of these tumors.
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